Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Global IPO Fund (IPOSX), the Renaissance IPO ETF (IPO) and institutional SMAs.
The JXM Database offers a non biased tool that is used to uncover stocks for superior future returns. The database is set up to rank the stocks against each other and the market with the final top ranks representing the best purchase opportunities
Trader since 1998; Trading Moderator, Coach & Mentor since 2006; Writer of a Trading Blog since 2007; Publishing Charts & Music since 2009. Operating a Trade List Service since 2010. Welcome to my Passion.